Drugs that contain Guanfacine Hydrochloride

1. List of Intuniv drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6811794 TAKEDA PHARMS USA Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
Jul, 2022

(8 months ago)

US6811794

(Pediatric)

TAKEDA PHARMS USA Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
Jan, 2023

(2 months ago)

Market Authorisation Date: 02 September, 2009

Treatment: Treatment of attention-deficit hyperactivity disorder

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of INTUNIV before it's patent expiration?
More Information on Dosage

INTUNIV family patents

1

United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic